Khiron Life Sciences Corp. (CVE:KHRN – Get Rating) shot up 25% on Thursday . The company traded as high as C$0.08 and last traded at C$0.08. 147,516 shares changed hands during mid-day trading, a decline of 5% from the average session volume of 156,018 shares. The stock had previously closed at C$0.06.
Khiron Life Sciences Price Performance
The company has a quick ratio of 0.72, a current ratio of 2.02 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of C$19.47 million and a price-to-earnings ratio of -0.47. The stock’s 50 day moving average price is C$0.07 and its two-hundred day moving average price is C$0.10.
Khiron Life Sciences Company Profile
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don’t Buy It Just Yet
Receive News & Ratings for Khiron Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Khiron Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.